Skip to main content
. 2021 Sep 24;11:19048. doi: 10.1038/s41598-021-98505-8

Table 3.

Multivariate Cox proportional analysis of factors associated with decline in renal function.

Variables Diabetes Non-diabetes
HR (95% CI) p HR (95% CI) p
Model 1
PSQ (no = 0, yes = 1) 2.15 (0.88–5.23) 0.091 2.20 (1.09–4.40) 0.025
Model 2
Sleep apnea (no = 0, yes = 1) 1.58 (0.51–4.92) 0.422 1.36 (0.70–2.63) 0.358
Model 3
Low HRV (no = 0, yes = 1) 2.40 (1.02–5.60) 0.043 0.81 (0.44–1.51) 0.525
Model 4
PSQ (no = 0, yes = 1) 2.10 (0.84–5.23) 0.110 2.38 (1.17–4.82) 0.015
Sleep apnea (no = 0, yes = 1) 1.54 (0.49–4.81) 0.457 1.24 (0.63–2.43) 0.527
Model 5
PSQ (no = 0, yes = 1) 2.60 (1.05–6.43) 0.038 2.37 (1.15–4.86) 0.018
Low HRV (no = 0, yes = 1) 2.60 (1.09–6.16) 0.029 0.79 (0.42–1.48) 0.470
Model 6
Sleep apnea (no = 0, yes = 1) 1.54 (0.49–4.79) 0.453 1.56 (0.77–3.16) 0.216
Low HRV (no = 0, yes = 1) 2.09 (0.87–4.97) 0.095 0.76 (0.41–1.43) 0.411
Model 7
PSQ (no = 0, yes = 1) 2.57 (1.01–6.53) 0.045 2.33 (1.12–4.84) 0.022
Sleep apnea (no = 0, yes = 1) 1.57 (0.49–5.03) 0.442 1.43 (0.69–2.94) 0.329
Low HRV (no = 0, yes = 1) 2.27 (0.94–5.47) 0.068 0.75 (0.39–1.42) 0.380

In all models used for multivariate Cox proportional hazards analysis, covariates included age, male gender, body mass index, current smoking, history of CVD, hypertension, dyslipidemia, HbA1c, baseline eGFR, and albuminuria. Model 1 included the presence of PSQ, Model 2 sleep apnea, Model 3 low HRV, Model 4 PSQ and sleep apnea, Model 5 PSQ and low HRV, Model 6 sleep apnea and low HRV, Model 7 PSQ, sleep apnea, and low HRV, in addition to the other covariates mentioned.

CVD cardiovascular disease, eGFR estimated glomerular filtration rate, PSQ poor sleep quality, HRV heart rate variability, HR hazard ratio, CI confidence interval.